Literature DB >> 17536730

Determination of the main bioactive metabolites of Radix salvia miltiorrhizae in compound Danshen dripping pills and the tissue distribution of Danshensu in rabbit by SPE-HPLC-MSn.

Zheng Xiaohui1, Zhao Xinfeng, Zhao Xin, Wang Shixiang, Wei Yinmao, Zheng Jianbin.   

Abstract

A fast solid phase extraction-high performance liquid chromatography-ion trap mass spectrometry (SPE-HPLC-MSn) method is presented for quantitative determination of 3-(3,4-dihydroxyphenyl)-2-hydroxylpropionic acid (Danshensu, DSS) from Compound Danshen Dripping Pills (CDDP) in rabbits' heart, liver, kidney, and lung and for qualitative analysis of the bioactive metabolites of Radix Salvia miltiorrhizae (DS) from CDDP in these tissues. The proposed method was validated with a detection limit of 0.06 ng/mL and a linear range of 5.0-200 ng/mL for DSS. The main metabolites of DS were pyrocatechol, vanillic acid, isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate, and 2-hydroxyl-3-(3,4-dihydroxyphenyl)propinonic sulfuric anhydride. In vitro pharmacological experiments demonstrated that isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate had a distinct vasodilatating action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536730     DOI: 10.1002/jssc.200600287

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  6 in total

1.  Tanshinol borneol ester, a novel synthetic small molecule angiogenesis stimulator inspired by botanical formulations for angina pectoris.

Authors:  Sha Liao; Liwen Han; Xiaopu Zheng; Xin Wang; Peng Zhang; Jingni Wu; Ruimin Liu; Youlan Fu; Jiaxin Sun; Ximeng Kang; Kechun Liu; Tai-Ping Fan; Shao Li; Xiaohui Zheng
Journal:  Br J Pharmacol       Date:  2019-07-09       Impact factor: 8.739

2.  A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway.

Authors:  Qian Yin; Haiyan Lu; Yajun Bai; Aiju Tian; Qiuxiang Yang; Jimin Wu; Chengzhi Yang; Tai-Ping Fan; Youyi Zhang; Xiaohui Zheng; Xiaopu Zheng; Zijian Li
Journal:  Br J Pharmacol       Date:  2015-05-05       Impact factor: 8.739

3.  The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation.

Authors:  Chunxiao Lv; Changxiao Liu; Zhuhua Yao; Xiumei Gao; Lanjun Sun; Jia Liu; Haibo Song; Ziqiang Li; Xi Du; Jinxia Sun; Yanfen Li; Kui Ye; Ruihua Wang; Yuhong Huang
Journal:  Front Pharmacol       Date:  2017-11-21       Impact factor: 5.810

4.  High-Throughput Determination of Sodium Danshensu in Beagle Dogs by the LCMS/MS Method, Employing Liquid-Liquid Extraction Based on 96-Well Format Plates.

Authors:  Jingjing Jiang; Xin Zhao; Xiuxiu Li; Shengyuan Wu; Shidan Yu; Yuefen Lou; Guorong Fan
Journal:  Molecules       Date:  2017-04-25       Impact factor: 4.411

5.  Metabonomic strategy to the evaluation of chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats.

Authors:  Xue Xin; Haimiao Zou; Ningning Zheng; Xinchun Xu; Yinmin Liu; Xiaoxian Wang; Hongbing Wu; Lina Lu; Jing Su; Mingfeng Qiu; Xiaoyan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-02       Impact factor: 2.629

6.  Protective Effects of L-Malate against Myocardial Ischemia/Reperfusion Injury in Rats.

Authors:  Shiao Ding; Yang Yang; Ju Mei
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-31       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.